Libor Pastika
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Libor Pastika has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Daniel B. Kramer
Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center and Harvard Medical School
7 shared publications - Fu Siong Ng
Imperial College London
7 shared publications - Konstantinos Patlatzoglou
National Heart and Lung Institute, Imperial College London , Hammersmith Campus, Du Cane Road, London W12 0NN
7 shared publications - Nicholas S. Peters
National Heart and Lung Institute, Imperial College London , Hammersmith Campus, Du Cane Road, London W12 0NN
7 shared publications - Arunashis Sau
National Heart and Lung Institute, Imperial College London , Du Cane Road, London W12 0NN
6 shared publications - Ewa Sieliwonczyk
National Heart and Lung Institute, Imperial College London , Hammersmith Campus, Du Cane Road, London W12 0NN
6 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal
Artificial intelligence-enhanced electrocardiography for detection and prediction of dilated cardiomyopathy
Background and Aims: A major challenge in dilated cardiomyopathy (DCM) care is the identification and management of individuals at risk before disease manifestation. An artificial intelligence (AI) model applied to electrocardiography (ECG) was developed to detect and predict the echocardiographic DCM phenotype (left ventricular dilatation with systolic dysfunction) and was evaluated for its ability to stratify the risk of incident DCM in familial cohorts. Methods: A deep learning model was trained to detect the echocardiographic DCM phenotype and to predict its future onset, using more than 330 000 ECG-echocardiogram pairs from the Beth Israel Deaconess Medical Center, Boston. Model performance was validated in cohorts from the UK Biobank, Zhongshan Hospital, and Antwerp University Hospital, and compared with models based on traditional ECG features and echocardiographic traits. To assess performance in familial DCM, genetically predisposed individuals identified through cascade screening at the cardiogenetics clinics of Antwerp University Hospital (n = 166, 18% DCM positive) and Maastricht University Medical Center (n = 177, 18% DCM positive) were evaluated. Results: The AI-ECG model achieved areas under the receiver operating characteristic curve of .87–.97 for diagnosing the prevalent DCM phenotype, outperforming traditional ECG parameters. AI-ECG was comparable to echocardiography for predicting future DCM (C-index .80–.87 and .80–.90, respectively). In familial cohorts, 5-year negative predictive values were 95.5% (Antwerp) and 91.5% (Maastricht), with corresponding positive predictive values of 42.4% and 39.4%, while high-risk scores were associated with a 5.1–6.4-fold increased risk of incident DCM. Conclusions: The explainable AI-ECG model detects the echocardiographic DCM phenotype and predicts future disease, and supports the exclusion of short- to mid-term disease in genetically at-risk individuals. This low-cost tool could help reduce surveillance burden and facilitate earlier intervention.
- 13 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal
Open AccessArtificial intelligence-enhanced electrocardiography for detection and prediction of dilated cardiomyopathy
Background and Aims: A major challenge in dilated cardiomyopathy (DCM) care is the identification and management of individuals at risk before disease manifestation. An artificial intelligence (AI) model applied to electrocardiography (ECG) was developed to detect and predict the echocardiographic DCM phenotype (left ventricular dilatation with systolic dysfunction) and was evaluated for its ability to stratify the risk of incident DCM in familial cohorts. Methods: A deep learning model was trained to detect the echocardiographic DCM phenotype and to predict its future onset, using more than 330 000 ECG-echocardiogram pairs from the Beth Israel Deaconess Medical Center, Boston. Model performance was validated in cohorts from the UK Biobank, Zhongshan Hospital, and Antwerp University Hospital, and compared with models based on traditional ECG features and echocardiographic traits. To assess performance in familial DCM, genetically predisposed individuals identified through cascade screening at the cardiogenetics clinics of Antwerp University Hospital (n = 166, 18% DCM positive) and Maastricht University Medical Center (n = 177, 18% DCM positive) were evaluated. Results: The AI-ECG model achieved areas under the receiver operating characteristic curve of .87–.97 for diagnosing the prevalent DCM phenotype, outperforming traditional ECG parameters. AI-ECG was comparable to echocardiography for predicting future DCM (C-index .80–.87 and .80–.90, respectively). In familial cohorts, 5-year negative predictive values were 95.5% (Antwerp) and 91.5% (Maastricht), with corresponding positive predictive values of 42.4% and 39.4%, while high-risk scores were associated with a 5.1–6.4-fold increased risk of incident DCM. Conclusions: The explainable AI-ECG model detects the echocardiographic DCM phenotype and predicts future disease, and supports the exclusion of short- to mid-term disease in genetically at-risk individuals. This low-cost tool could help reduce surveillance burden and facilitate earlier intervention.
- Open Access
- 22 July 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 7 (7)
Artificial intelligence-enhanced electrocardiography for the prediction of future type 2 diabetes mellitus: a model-development and multicentre validation study
Aims: A significant proportion of type 2 diabetes cases remain undiagnosed despite screening advances, carrying substantial cardiometabolic risk. Artificial intelligence-enhanced electrocardiography (AI-ECG) detects subtle ECG changes in subclinical disease, potentially enabling opportunistic screening. Methods and results: We developed AI-ECG Risk Estimator for Diabetes Mellitus (AIRE-DM), a convolutional neural network with discrete-time survival loss, for diagnosis of prevalent and prediction of incident type 2 diabetes. It was trained on 1 163 401 ECGs from 189 537 individuals from Beth Israel Deaconess Medical Center (BIDMC) and externally validated in UK Biobank (UKB; n = 65 606) and ELSA-Brasil (n = 13 739). AI-ECG Risk Estimator for Diabetes Mellitus demonstrated moderate discrimination for prevalent type 2 diabetes (area under the receiver operating characteristic curve: BIDMC 0.724, UKB 0.733, ELSA-Brasil 0.706) and incident type 2 diabetes (C-index: BIDMC 0.667, UKB 0.688, ELSA-Brasil 0.625). The highest AIRE-DM risk quartile had elevated incident diabetes risk vs. the lowest (hazard ratio: BIDMC 4.75, UKB 7.52, ELSA-Brasil 3.96). AI-ECG Risk Estimator for Diabetes Mellitus was non-inferior to the American Diabetes Association Diabetes Risk Test in BIDMC, with improved predictive accuracy when combined. In normoglycaemic patients, AIRE-DM was superior to glycated haemoglobin (HbA1c) for predicting incident diabetes in BIDMC and non-inferior in ELSA-Brasil. The highest risk quartile reached 5% cumulative type 2 diabetes mellitus incidence 5.4 years (BIDMC) and 4.8 years (ELSA-Brasil) earlier than the lowest risk quartile, after adjusting for HbA1c, age, and sex. Phenome- and genome-wide association studies revealed biologically plausible associations with glucose regulation, cardiac morphology, diastolic dysfunction, arterial stiffness, and lipid metabolism. Conclusion: AI-ECG Risk Estimator for Diabetes Mellitus detects prevalent type 2 diabetes and predicts incident disease, uniquely identifying high-risk individuals within the normoglycaemic range. Combined with clinical scores or biomarkers, it enhances risk stratification, enabling earlier intervention.
- 22 July 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 7 (7)
Open AccessArtificial intelligence-enhanced electrocardiography for the prediction of future type 2 diabetes mellitus: a model-development and multicentre validation study
Aims: A significant proportion of type 2 diabetes cases remain undiagnosed despite screening advances, carrying substantial cardiometabolic risk. Artificial intelligence-enhanced electrocardiography (AI-ECG) detects subtle ECG changes in subclinical disease, potentially enabling opportunistic screening. Methods and results: We developed AI-ECG Risk Estimator for Diabetes Mellitus (AIRE-DM), a convolutional neural network with discrete-time survival loss, for diagnosis of prevalent and prediction of incident type 2 diabetes. It was trained on 1 163 401 ECGs from 189 537 individuals from Beth Israel Deaconess Medical Center (BIDMC) and externally validated in UK Biobank (UKB; n = 65 606) and ELSA-Brasil (n = 13 739). AI-ECG Risk Estimator for Diabetes Mellitus demonstrated moderate discrimination for prevalent type 2 diabetes (area under the receiver operating characteristic curve: BIDMC 0.724, UKB 0.733, ELSA-Brasil 0.706) and incident type 2 diabetes (C-index: BIDMC 0.667, UKB 0.688, ELSA-Brasil 0.625). The highest AIRE-DM risk quartile had elevated incident diabetes risk vs. the lowest (hazard ratio: BIDMC 4.75, UKB 7.52, ELSA-Brasil 3.96). AI-ECG Risk Estimator for Diabetes Mellitus was non-inferior to the American Diabetes Association Diabetes Risk Test in BIDMC, with improved predictive accuracy when combined. In normoglycaemic patients, AIRE-DM was superior to glycated haemoglobin (HbA1c) for predicting incident diabetes in BIDMC and non-inferior in ELSA-Brasil. The highest risk quartile reached 5% cumulative type 2 diabetes mellitus incidence 5.4 years (BIDMC) and 4.8 years (ELSA-Brasil) earlier than the lowest risk quartile, after adjusting for HbA1c, age, and sex. Phenome- and genome-wide association studies revealed biologically plausible associations with glucose regulation, cardiac morphology, diastolic dysfunction, arterial stiffness, and lipid metabolism. Conclusion: AI-ECG Risk Estimator for Diabetes Mellitus detects prevalent type 2 diabetes and predicts incident disease, uniquely identifying high-risk individuals within the normoglycaemic range. Combined with clinical scores or biomarkers, it enhances risk stratification, enabling earlier intervention.
- Open Access
- 16 July 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (44) , 4823-4837
Artificial intelligence-enhanced electrocardiography to predict regurgitant valvular heart diseases: an international study
Background and Aims: Valvular heart disease (VHD) is a significant source of morbidity and mortality, though early intervention can improve outcomes. This study aims to develop artificial intelligence-enhanced electrocardiography (AI-ECG) models to diagnose and predict future moderate or severe regurgitant VHDs (rVHDs), including mitral regurgitation (MR), tricuspid regurgitation (TR), and aortic regurgitation (AR). Methods: The AI-ECG models were developed in a data set of 988 618 ECG and transthoracic echocardiogram pairs from 400 882 patients from Zhongshan Hospital, Shanghai, China. The AI-ECG models used a residual convolutional neural network with a discrete-time survival loss function. External evaluation was performed in outpatients from a secondary care data set from Beth Israel Deaconess Medical Center, Boston, USA, consisting of 34 214 patients with linked echocardiography. Results: In the internal test set, the AI-ECG models accurately predicted future significant MR [C-index 0.774, 95% confidence interval (CI) 0.753–0.792], AR (0.691, 95% CI 0.657–0.720), and TR (0.793, 95% CI 0.777–0.808). In age- and sex-adjusted Cox models, the highest risk quartile had a hazard ratio (HR) of 7.6 (95% CI 5.8–9.9, P < .0001) for risk of future significant MR, compared with the lowest risk quartile. For future AR and TR, the equivalent HRs were 3.8 (95% CI 2.7–5.5) and 9.9 (95% CI 7.5–13.0), respectively. These findings were confirmed in the transnational external test set. Imaging association analyses demonstrated AI-ECG predictions were associated with subclinical chamber remodelling. Conclusions: This study developed AI-ECG models to diagnose and predict rVHDs and validated the models in a transnational and ethnically distinct cohort. The AI-ECG models could be utilized to guide surveillance echocardiography in patients at risk of future rVHDs, to facilitate early detection and intervention.
- 16 July 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (44) , 4823-4837
Open AccessArtificial intelligence-enhanced electrocardiography to predict regurgitant valvular heart diseases: an international study
Background and Aims: Valvular heart disease (VHD) is a significant source of morbidity and mortality, though early intervention can improve outcomes. This study aims to develop artificial intelligence-enhanced electrocardiography (AI-ECG) models to diagnose and predict future moderate or severe regurgitant VHDs (rVHDs), including mitral regurgitation (MR), tricuspid regurgitation (TR), and aortic regurgitation (AR). Methods: The AI-ECG models were developed in a data set of 988 618 ECG and transthoracic echocardiogram pairs from 400 882 patients from Zhongshan Hospital, Shanghai, China. The AI-ECG models used a residual convolutional neural network with a discrete-time survival loss function. External evaluation was performed in outpatients from a secondary care data set from Beth Israel Deaconess Medical Center, Boston, USA, consisting of 34 214 patients with linked echocardiography. Results: In the internal test set, the AI-ECG models accurately predicted future significant MR [C-index 0.774, 95% confidence interval (CI) 0.753–0.792], AR (0.691, 95% CI 0.657–0.720), and TR (0.793, 95% CI 0.777–0.808). In age- and sex-adjusted Cox models, the highest risk quartile had a hazard ratio (HR) of 7.6 (95% CI 5.8–9.9, P < .0001) for risk of future significant MR, compared with the lowest risk quartile. For future AR and TR, the equivalent HRs were 3.8 (95% CI 2.7–5.5) and 9.9 (95% CI 7.5–13.0), respectively. These findings were confirmed in the transnational external test set. Imaging association analyses demonstrated AI-ECG predictions were associated with subclinical chamber remodelling. Conclusions: This study developed AI-ECG models to diagnose and predict rVHDs and validated the models in a transnational and ethnically distinct cohort. The AI-ECG models could be utilized to guide surveillance echocardiography in patients at risk of future rVHDs, to facilitate early detection and intervention.
- Open Access
- 1 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (13) , e040814
Revisiting Abnormalities of Ventricular Depolarization: Redefining Phenotypes and Associated Outcomes Using Tree‐Based Dimensionality Reduction
Background: Abnormal ventricular depolarization, evident as a broad QRS complex on an ECG, is traditionally categorized into left bundle‐branch block (LBBB) and right bundle‐branch block or nonspecific intraventricular conduction delay. This categorization, although physiologically accurate, may fail to capture the nuances of diseases subtypes. Methods: We used unsupervised machine learning to identify and characterize novel broad QRS phenogroups. First, we trained a variational autoencoder on 1.1 million ECGs and discovered 51 latent features that showed high disentanglement and ECG reconstruction accuracy. We then extracted these features from 42 538 ECGs with QRS durations >120 milliseconds and employed a reversed graph embedding method to model population heterogeneity as a tree structure with different branches representing phenogroups. Results: Six phenogroups were identified, including phenogroups of right bundle‐branch block and LBBB with varying risk of cardiovascular disease and mortality. The higher risk right bundle‐branch block phenogroup exhibited increased risk of cardiovascular death (adjusted hazard ratio [aHR], 1.46 [1.30–1.63], P P P <0.05). Conclusions: Our findings challenge the current paradigm, highlighting the potential for these phenogroups to enhance cardiac resynchronization therapy patient selection for subjects with LBBB and guide investigation and follow‐up strategies for subjects with higher risk right bundle‐branch block.
- 1 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (13) , e040814
Open AccessRevisiting Abnormalities of Ventricular Depolarization: Redefining Phenotypes and Associated Outcomes Using Tree‐Based Dimensionality Reduction
Background: Abnormal ventricular depolarization, evident as a broad QRS complex on an ECG, is traditionally categorized into left bundle‐branch block (LBBB) and right bundle‐branch block or nonspecific intraventricular conduction delay. This categorization, although physiologically accurate, may fail to capture the nuances of diseases subtypes. Methods: We used unsupervised machine learning to identify and characterize novel broad QRS phenogroups. First, we trained a variational autoencoder on 1.1 million ECGs and discovered 51 latent features that showed high disentanglement and ECG reconstruction accuracy. We then extracted these features from 42 538 ECGs with QRS durations >120 milliseconds and employed a reversed graph embedding method to model population heterogeneity as a tree structure with different branches representing phenogroups. Results: Six phenogroups were identified, including phenogroups of right bundle‐branch block and LBBB with varying risk of cardiovascular disease and mortality. The higher risk right bundle‐branch block phenogroup exhibited increased risk of cardiovascular death (adjusted hazard ratio [aHR], 1.46 [1.30–1.63], P P P <0.05). Conclusions: Our findings challenge the current paradigm, highlighting the potential for these phenogroups to enhance cardiac resynchronization therapy patient selection for subjects with LBBB and guide investigation and follow‐up strategies for subjects with higher risk right bundle‐branch block.
- Open Access
- 25 February 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 6 (3) , 417-426
Siamese neural network-enhanced electrocardiography can re-identify anonymized healthcare data
Aims: Many research databases with anonymized patient data contain electrocardiograms (ECGs) from which traditional identifiers have been removed. We evaluated the ability of artificial intelligence (AI) methods to determine the similarity between ECGs and assessed whether they have the potential to be misused to re-identify individuals from anonymized datasets. Methods and results: We utilized a convolutional Siamese neural network (SNN) architecture, which derives a Euclidean distance similarity metric between two input ECGs. A secondary care dataset of 864 283 ECGs (72 455 subjects) was used. Siamese neural network-electrocardiogram (SNN-ECG) achieves an accuracy of 91.68% when classifying between 2 689 124 same-subject pairs and 2 689 124 different-subject pairs. This performance increases to 93.61% and 95.97% in outpatient and normal ECG subsets. In a simulated ‘motivated intruder’ test, SNN-ECG can identify individuals from large datasets. In datasets of 100, 1000, 10 000, and 20 000 ECGs, where only one ECG is also from the reference individual, it achieves success rates of 79.2%, 62.6%, 45.0%, and 40.0%, respectively. If this was random, the success would be 1%, 0.1%, 0.01%, and 0.005%, respectively. Additional basic information, like subject sex or age-range, enhances performance further. We also found that, on the subject level, ECG pair similarity is clinically relevant; greater ECG dissimilarity associates with all-cause mortality [hazard ratio, 1.22 (1.21–1.23), P < 0.0001] and is additive to an AI-ECG model trained for mortality prediction. Conclusion: Anonymized ECGs retain information that may facilitate subject re-identification, raising privacy and data protection concerns. However, SNN-ECG models also have positive uses and can enhance risk prediction of cardiovascular disease.
- 25 February 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 6 (3) , 417-426
Open AccessSiamese neural network-enhanced electrocardiography can re-identify anonymized healthcare data
Aims: Many research databases with anonymized patient data contain electrocardiograms (ECGs) from which traditional identifiers have been removed. We evaluated the ability of artificial intelligence (AI) methods to determine the similarity between ECGs and assessed whether they have the potential to be misused to re-identify individuals from anonymized datasets. Methods and results: We utilized a convolutional Siamese neural network (SNN) architecture, which derives a Euclidean distance similarity metric between two input ECGs. A secondary care dataset of 864 283 ECGs (72 455 subjects) was used. Siamese neural network-electrocardiogram (SNN-ECG) achieves an accuracy of 91.68% when classifying between 2 689 124 same-subject pairs and 2 689 124 different-subject pairs. This performance increases to 93.61% and 95.97% in outpatient and normal ECG subsets. In a simulated ‘motivated intruder’ test, SNN-ECG can identify individuals from large datasets. In datasets of 100, 1000, 10 000, and 20 000 ECGs, where only one ECG is also from the reference individual, it achieves success rates of 79.2%, 62.6%, 45.0%, and 40.0%, respectively. If this was random, the success would be 1%, 0.1%, 0.01%, and 0.005%, respectively. Additional basic information, like subject sex or age-range, enhances performance further. We also found that, on the subject level, ECG pair similarity is clinically relevant; greater ECG dissimilarity associates with all-cause mortality [hazard ratio, 1.22 (1.21–1.23), P < 0.0001] and is additive to an AI-ECG model trained for mortality prediction. Conclusion: Anonymized ECGs retain information that may facilitate subject re-identification, raising privacy and data protection concerns. However, SNN-ECG models also have positive uses and can enhance risk prediction of cardiovascular disease.
- Open Access
- 25 February 2025
- Published by Elsevier in The Lancet Digital Health
- Vol. 7 (3) , e184-e194
Artificial intelligence-enhanced electrocardiography for the identification of a sex-related cardiovascular risk continuum: a retrospective cohort study
- 25 February 2025
- Published by Elsevier in The Lancet Digital Health
- Vol. 7 (3) , e184-e194
Open AccessArtificial intelligence-enhanced electrocardiography for the identification of a sex-related cardiovascular risk continuum: a retrospective cohort study
- Open Access
- 1 December 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 17 (12) , e010602
Prognostic Significance and Associations of Neural Network–Derived Electrocardiographic Features
BACKGROUND: Subtle, prognostically important ECG features may not be apparent to physicians. In the course of supervised machine learning, thousands of ECG features are identified. These are not limited to conventional ECG parameters and morphology. We aimed to investigate whether neural network–derived ECG features could be used to predict future cardiovascular disease and mortality and have phenotypic and genotypic associations. METHODS: We extracted 5120 neural network–derived ECG features from an artificial intelligence–enabled ECG model trained for 6 simple diagnoses and applied unsupervised machine learning to identify 3 phenogroups. Using the identified phenogroups, we externally validated our findings in 5 diverse cohorts from the United States, Brazil, and the United Kingdom. Data were collected between 2000 and 2023. RESULTS: In total, 1 808 584 patients were included in this study. In the derivation cohort, the 3 phenogroups had significantly different mortality profiles. After adjusting for known covariates, phenogroup B had a 20% increase in long-term mortality compared with phenogroup A (hazard ratio, 1.20 [95% CI, 1.17–1.23]; P P P P P P SCN10A , SCN5A , and CAV1 have roles in cardiac conduction and arrhythmia. ARHGAP24 does not have a clear cardiac role and may be a novel target. CONCLUSIONS: Neural network–derived ECG features can be used to predict all-cause mortality and future cardiovascular diseases. We have identified biologically plausible and novel phenotypic and genotypic associations that describe mechanisms for the increased risk identified.
- 1 December 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 17 (12) , e010602
Open AccessPrognostic Significance and Associations of Neural Network–Derived Electrocardiographic Features
BACKGROUND: Subtle, prognostically important ECG features may not be apparent to physicians. In the course of supervised machine learning, thousands of ECG features are identified. These are not limited to conventional ECG parameters and morphology. We aimed to investigate whether neural network–derived ECG features could be used to predict future cardiovascular disease and mortality and have phenotypic and genotypic associations. METHODS: We extracted 5120 neural network–derived ECG features from an artificial intelligence–enabled ECG model trained for 6 simple diagnoses and applied unsupervised machine learning to identify 3 phenogroups. Using the identified phenogroups, we externally validated our findings in 5 diverse cohorts from the United States, Brazil, and the United Kingdom. Data were collected between 2000 and 2023. RESULTS: In total, 1 808 584 patients were included in this study. In the derivation cohort, the 3 phenogroups had significantly different mortality profiles. After adjusting for known covariates, phenogroup B had a 20% increase in long-term mortality compared with phenogroup A (hazard ratio, 1.20 [95% CI, 1.17–1.23]; P P P P P P SCN10A , SCN5A , and CAV1 have roles in cardiac conduction and arrhythmia. ARHGAP24 does not have a clear cardiac role and may be a novel target. CONCLUSIONS: Neural network–derived ECG features can be used to predict all-cause mortality and future cardiovascular diseases. We have identified biologically plausible and novel phenotypic and genotypic associations that describe mechanisms for the increased risk identified.
- Open Access
- 25 June 2024
- Published by Springer Nature in npj Digital Medicine
- Vol. 7 (1) , 1-16
Artificial intelligence-enhanced electrocardiography derived body mass index as a predictor of future cardiometabolic disease
The electrocardiogram (ECG) can capture obesity-related cardiac changes. Artificial intelligence-enhanced ECG (AI-ECG) can identify subclinical disease. We trained an AI-ECG model to predict body mass index (BMI) from the ECG alone. Developed from 512,950 12-lead ECGs from the Beth Israel Deaconess Medical Center (BIDMC), a secondary care cohort, and validated on UK Biobank (UKB) (n = 42,386), the model achieved a Pearson correlation coefficient (r) of 0.65 and 0.62, and an R2 of 0.43 and 0.39 in the BIDMC cohort and UK Biobank, respectively for AI-ECG BMI vs. measured BMI. We found delta-BMI, the difference between measured BMI and AI-ECG-predicted BMI (AI-ECG-BMI), to be a biomarker of cardiometabolic health. The top tertile of delta-BMI showed increased risk of future cardiometabolic disease (BIDMC: HR 1.15, p < 0.001; UKB: HR 1.58, p < 0.001) and diabetes mellitus (BIDMC: HR 1.25, p < 0.001; UKB: HR 2.28, p < 0.001) after adjusting for covariates including measured BMI. Significant enhancements in model fit, reclassification and improvements in discriminatory power were observed with the inclusion of delta-BMI in both cohorts. Phenotypic profiling highlighted associations between delta-BMI and cardiometabolic diseases, anthropometric measures of truncal obesity, and pericardial fat mass. Metabolic and proteomic profiling associates delta-BMI positively with valine, lipids in small HDL, syntaxin-3, and carnosine dipeptidase 1, and inversely with glutamine, glycine, colipase, and adiponectin. A genome-wide association study revealed associations with regulators of cardiovascular/metabolic traits, including SCN10A, SCN5A, EXOG and RXRG. In summary, our AI-ECG-BMI model accurately predicts BMI and introduces delta-BMI as a non-invasive biomarker for cardiometabolic risk stratification.
- 25 June 2024
- Published by Springer Nature in npj Digital Medicine
- Vol. 7 (1) , 1-16
Open AccessArtificial intelligence-enhanced electrocardiography derived body mass index as a predictor of future cardiometabolic disease
The electrocardiogram (ECG) can capture obesity-related cardiac changes. Artificial intelligence-enhanced ECG (AI-ECG) can identify subclinical disease. We trained an AI-ECG model to predict body mass index (BMI) from the ECG alone. Developed from 512,950 12-lead ECGs from the Beth Israel Deaconess Medical Center (BIDMC), a secondary care cohort, and validated on UK Biobank (UKB) (n = 42,386), the model achieved a Pearson correlation coefficient (r) of 0.65 and 0.62, and an R2 of 0.43 and 0.39 in the BIDMC cohort and UK Biobank, respectively for AI-ECG BMI vs. measured BMI. We found delta-BMI, the difference between measured BMI and AI-ECG-predicted BMI (AI-ECG-BMI), to be a biomarker of cardiometabolic health. The top tertile of delta-BMI showed increased risk of future cardiometabolic disease (BIDMC: HR 1.15, p < 0.001; UKB: HR 1.58, p < 0.001) and diabetes mellitus (BIDMC: HR 1.25, p < 0.001; UKB: HR 2.28, p < 0.001) after adjusting for covariates including measured BMI. Significant enhancements in model fit, reclassification and improvements in discriminatory power were observed with the inclusion of delta-BMI in both cohorts. Phenotypic profiling highlighted associations between delta-BMI and cardiometabolic diseases, anthropometric measures of truncal obesity, and pericardial fat mass. Metabolic and proteomic profiling associates delta-BMI positively with valine, lipids in small HDL, syntaxin-3, and carnosine dipeptidase 1, and inversely with glutamine, glycine, colipase, and adiponectin. A genome-wide association study revealed associations with regulators of cardiovascular/metabolic traits, including SCN10A, SCN5A, EXOG and RXRG. In summary, our AI-ECG-BMI model accurately predicts BMI and introduces delta-BMI as a non-invasive biomarker for cardiometabolic risk stratification.
- Open Access
- 1 August 2021
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 5 (8) , ytab282
Case report of subacute presentation of tricuspid valve thrombus complicated by widespread bilateral pulmonary emboli: a multifactorial aetiology
Background : Right heart thrombus (RHTh) complicated by pulmonary embolism (PE) usually presents as a medical emergency with significant haemodynamic instability. However, less is known about subacute presentations. Case summary : We present a 74-year-old haemodynamically stable gentleman with a 3-week history of mild pleuritic chest pain and exertional dyspnoea preceded by lower respiratory tract infection. Early trans-thoracic echocardiogram (TTE) revealed a 3 cm elongated tricuspid valve thrombus with right ventricular dysfunction, new-onset atrial fibrillation, and new-onset severe left ventricular impairment. Subsequent computed tomography pulmonary angiogram showed widespread bilateral pulmonary emboli with retrograde opacification of the hepatic veins. The RHTh successfully resolved with warfarin therapy with no further complications, and the patient was discharged on Day 8 of hospitalization. Discussion : An early TTE is crucial in detecting the RHTh in patients suspected of PE and can significantly change the management compared with uncomplicated PE. The index of suspicion for PE and RHTh should remain high even in subacute cases.
- 1 August 2021
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 5 (8) , ytab282
Open AccessCase report of subacute presentation of tricuspid valve thrombus complicated by widespread bilateral pulmonary emboli: a multifactorial aetiology
Background : Right heart thrombus (RHTh) complicated by pulmonary embolism (PE) usually presents as a medical emergency with significant haemodynamic instability. However, less is known about subacute presentations. Case summary : We present a 74-year-old haemodynamically stable gentleman with a 3-week history of mild pleuritic chest pain and exertional dyspnoea preceded by lower respiratory tract infection. Early trans-thoracic echocardiogram (TTE) revealed a 3 cm elongated tricuspid valve thrombus with right ventricular dysfunction, new-onset atrial fibrillation, and new-onset severe left ventricular impairment. Subsequent computed tomography pulmonary angiogram showed widespread bilateral pulmonary emboli with retrograde opacification of the hepatic veins. The RHTh successfully resolved with warfarin therapy with no further complications, and the patient was discharged on Day 8 of hospitalization. Discussion : An early TTE is crucial in detecting the RHTh in patients suspected of PE and can significantly change the management compared with uncomplicated PE. The index of suspicion for PE and RHTh should remain high even in subacute cases.